These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. An ELISA for tissue factor using monoclonal antibodies. Albrecht S; Luther T; Grossmann H; Flössel C; Kotzsch M; Müller M Blood Coagul Fibrinolysis; 1992 Jun; 3(3):263-70. PubMed ID: 1643203 [TBL] [Abstract][Full Text] [Related]
24. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Moll R; Mitze M; Frixen UH; Birchmeier W Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical distribution pattern of intermediate filament proteins and muscle actin in feline and human mammary carcinomas. Martín de las Mulas J; Espinosa de los Monteros A; Bautista MJ; Gómez-Villamandos JC; Morales C J Comp Pathol; 1994 Nov; 111(4):365-81. PubMed ID: 7533801 [TBL] [Abstract][Full Text] [Related]
26. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma. Tuszynski GP; Nicosia RF Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188 [TBL] [Abstract][Full Text] [Related]
27. Analysis of the tumour-associated antigen TAG-12 by monoclonal antibody 7A9 in normal, benign and malignant mammary tissues. Werner M; von Wasielewski R; Bernhards J; Georgii A Virchows Arch A Pathol Anat Histopathol; 1990; 416(5):411-6. PubMed ID: 2156377 [TBL] [Abstract][Full Text] [Related]
28. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. Gill S; Peston D; Vonderhaar BK; Shousha S J Clin Pathol; 2001 Dec; 54(12):956-60. PubMed ID: 11729217 [TBL] [Abstract][Full Text] [Related]
29. Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Jin L; Fuchs A; Schnitt SJ; Yao Y; Joseph A; Lamszus K; Park M; Goldberg ID; Rosen EM Cancer; 1997 Feb; 79(4):749-60. PubMed ID: 9024713 [TBL] [Abstract][Full Text] [Related]
30. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation. Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618 [TBL] [Abstract][Full Text] [Related]
31. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D. Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas. Foster CS; Dinsdale EA; Edwards PA; Neville AM Virchows Arch A Pathol Anat Histol; 1982; 394(3):295-305. PubMed ID: 6176068 [TBL] [Abstract][Full Text] [Related]
33. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Arklie J; Taylor-Papadimitrious J; Bodmer W; Egan M; Millis R Int J Cancer; 1981 Jul; 28(1):23-9. PubMed ID: 6273328 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of the distribution of a breast tumor associated antigen recognized by a monoclonal antibody. Castagna M; Viacava P; Turchi V; Rughetti A; Nuti M; Squartini F Pathol Res Pract; 1992 Dec; 188(8):1002-8. PubMed ID: 1300596 [TBL] [Abstract][Full Text] [Related]
35. Expression of tumour associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study. Croce MV; Colussi AG; Price MR; Segal-Eiras A Anticancer Res; 1997; 17(6D):4287-92. PubMed ID: 9494522 [TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Jarasch ED; Nagle RB; Kaufmann M; Maurer C; Böcker WJ Hum Pathol; 1988 Mar; 19(3):276-89. PubMed ID: 2450059 [TBL] [Abstract][Full Text] [Related]
37. The use of a totally human monoclonal antibody for the staining of primary and metastatic human breast tumors. Strelkauskas AJ; Welsh J; Metcalf JS; Aldenderfer PH Hum Antibodies Hybridomas; 1994; 5(3-4):157-64. PubMed ID: 7756580 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours. Pallud C; Le Doussal V; Pichon MF; Prud'homme JF; Hacene K; Milgrom E Histopathology; 1993 Sep; 23(3):249-56. PubMed ID: 8225243 [TBL] [Abstract][Full Text] [Related]
39. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Tanaka A; Furuya A; Yamasaki M; Hanai N; Kuriki K; Kamiakito T; Kobayashi Y; Yoshida H; Koike M; Fukayama M Cancer Res; 1998 May; 58(10):2053-6. PubMed ID: 9605740 [TBL] [Abstract][Full Text] [Related]
40. Keratin expression in the normal breast and in breast carcinoma. Tsubura A; Okada H; Senzaki H; Hatano T; Morii S Histopathology; 1991 Jun; 18(6):517-22. PubMed ID: 1715306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]